-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HCV-IN-36
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2757963-81-6.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 2757963-81-6 |
| Description | HCV-IN-36 (compound (S)-3h) is an orally active and potent HCV entry inhibitor. HCV-IN-36 shows excellent antiviral activity, with an EC50 of 0.016 μM and a CC50 (half-maximal cytotoxic concentration) of 8.78 μM. |
Product Information
| Synonyms | HCV-IN-36|HY-144109|CS-0376521 |
| Molecular Weight | 502.09 |
| Molecular Formula | C30H36ClN5 |
| Canonical SMILES | CN(C)CCN(C)C1=CC(=C(C=C1)C#N)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 685 |
| Exact Mass | 501.2659239 |
| Target | EC50: 0.010 ± 0.007 μM (HCV) |
| XLogP3-AA | 5.3 |
